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Background: Estradiol plays an important role in the regulation of collagen metabolism. Deficiency of estradiol has
been reported to be associated with the degeneration of many connective tissues. However, the association of estradiol
and hypertrophy of the ligamentum flavum was seldom explored. Therefore, we studied the effects of estradiol on
cultured cells from the ligamentum flavum.
Methods: Primary cultures of human ligamentum flavum cells obtained from surgical specimens of 14 patients
undergoing spinal surgery were used to investigate the effect of estradiol on cell proliferation and the expression of
collagen, elastin, and matrix metalloproteinases. Downstream pathways of estrogen receptor underlying the regulation
of metalloproteinases were also investigated.
Results: In our study, we revealed the existence of estrogen receptors on both female and male ligamentum flavum
cells with a gender difference. 17β-estradiol increased early (24 hours) proliferation of ligamentum flavum cells in a dose
dependent manner and the effect could not be seen when the cell density increased. Estradiol with a concentration of
10-9 M decreased collagen levels and increased the expression of MMP-13. Adding an antagonist of PI3K downstream
pathway could reverse the expression of MMP-13 caused by estradiol.
Conclusions: The results implied estradiol regulated the expression of MMP-13 via PI3K pathway and contributed to the
homeostasis of extracellular matrix in the ligamentum flavum.
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Lumbar spinal stenosis is one of the most common
spinal disorders in the elderly patients [1]. Hypertrophy
of the ligamentum flavum (LF) in combination with
osteophyte formation of facet joints and degenerative
spondylolisthesis can contribute to the development of
lumbar spinal stenosis [2]. Although it is agreed that
spinal mechanical stress accelerates the hypertrophy of
ligamentum flavum which contributes to the development
of spondylotic stenosis of the lumbar spine [3], the
detailed underlying mechanism is not fully understood. A
recent population-based cohort study in Japan revealed* Correspondence: chen.minghong@gmail.com
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unless otherwise stated.the prevalence of lumbar spinal stenosis for women was
higher in increased age but showed only little difference in
men with age greater than 70 years [4]. Matveeva et al also
reported that lumbar stenosis in older female patients
often involves more vertebral bodies than that in older
male [5]. These evidences suggested that difference in
genders plays a certain role in the pathogenesis of lumbar
spinal stenosis. Therefore, we suspected that estradiol,
as an important hormone during the aging processes
in different genders, has a role in the development of
degenerative spinal stenosis. It is also well recognized
that estradiol deficiency is the major factor contributing to
bone loss and osteoporotic vertebral fracture after
menopause. However, previous studies showed that
there is an inverse relation between osteoporosis and
lumbar spondylotic stenosis in postmenopausal women
[6]. Hence, we believed estradiol might have influences ontd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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through the matrix metabolism of spinal ligaments
rather than its effects on vertebral bony structures.
The ligamentum flavum, as a key spinal ligament, also
named the yellow ligament because of its richness in
yellow elastin. It contains 60%-70% of elastic fibers
[7] and, between elastic fibers, there were small diameter
collagen fibrils, which were linked with the proteoglycans
[8]. Degenerative ligamentum flavum in lumbar stenosis
showed decreased elasticity and increased fibrosis. The
degree of fibrosis and the ligamentum flavum thickness
had a positive correlation [9]. The increased collagen-to-
elastin ratio has also been considered as a sign of
developing lumbar spinal stenosis in elder patients
[10]. On the other hand, estradiol plays an important
role in the regulation of collagen metabolism [11].
Deficiency of estradiol has been reported to be associated
with collagen metabolism and the subsequent degeneration
of skin, arteries, bone and intervertebral discs [11-13].
Previous studies also revealed that estradiol can increase
the expression of elastin in rat Achilles tendon fibroblasts
[14], rat prostates [15], human smooth muscles [16], and
skin [17]. Estradiol can even stimulate the enzyme activity
and accelerate the maturation of collagen and elastin in
extracellular space in mice [18]. Contrarily, other reports
suggest estradiol can interfere with elastin expression via
TGF-β signalling and result in improper assembly of
elastic fibers [19]. However, the association of estradiol
and matrix metabolism of the ligamentum flavum had
seldom been explored. Furthermore, the extracellular
matrix molecules can be degraded only by specific
enzyme, particularly the various metalloproteinases
(MMPs), which are the main players in the catabolism of
collagen molecules. The MMPs can be divided into
four groups [20] on the basis of substrate specificity (namely
collagenase, gelatinase, stromelysins, and membrane-type
MMPs). Among various MMPs, MMP-1 and MMP-13 can
cleave intact interstitial collagen molecules. In addition,
MMP-2 and MMP-9 can degrade denatured collagen
molecules and basement membrane collagens. To under-
stand the equilibrium between matrix degradation and
synthesis in the aging and /or degenerative ligamentum
flavum, it is important to evaluate the expression and
activity of MMPs. In the present work, we investigated the
effects of estradiol on cultured human ligamentum flavum
cells by examining the presence of estradiol receptors,
effects of estradiol on cell proliferation, regulation of
collagen and elastin metabolisms, the relationship of matrix
metalloproteinases (MMPs) with estradiol treatment
and the signaling mechanisms underlying it. The benefits
of estrogen replacement therapy in osteoporosis and
related bone fracture have been well established. Through
this study, the understandings of estradiol’s effects on cell
proliferation and matrix metabolism of the ligamentumflavum should provide more insights into the influences of
estradiol on the pathophysiology of spondylotic lumbar
stenosis during aging in women.
Methods
Sample collection
Surgical specimens of ligamentum flavum were obtained
from 14 patients (8 female and 6 male, mean age was
58.8, range from 45 to 78 years) undergoing spinal
surgery under the diagnosis of lumbar spinal stenosis
with or without spondylolisthesis, herniated intervertebral
disc, and degenerative disc disease. Written informed
consent for participation in this study was obtained from
all participants. Two samples were used for immunohisto-
chemistry and the rest of the samples were pooled for
studies due to low cellularity and limited proliferation
capacity of LF. All the study procedures received ap-
proval of the Ethic Committee of Taipei City Hospital
(TCHIRB-980307-E).
Culture of human LF cells
The specimens were washed twice in phosphate-buffered
saline (PBS) with penicillin-streptomycin, cut into small
pieces (approximately 1.0 mm3), and placed in a 10 cm
culture dish with 7 ml of high glucose Dulbecco’s
Modified Eagle Medium (DMEM) with 10% fetal bovine
serum (FBS) and 100 IU/mL penicillin/streptomycin.
Cultures were maintained at 37°C in a water-saturated
atmosphere of 95% air and 5% CO2. Cells under passaged
3-6 were used in the following experiments.
Immunohistochemistry
One male sample and one female sample were used
separately to evaluate the presence of estrogen receptors
on cells from both genders. Cells were collected by
centrifuge and cytospin was used to make cells attach on
the slides. Cells on the slides were fixed by 95% alcohol
and stained with haematoxylin and estrogen receptor α
and β. Antibodies for immunohistochemical staining of
estrogen receptors were purchased from Thermo Fisher
Scientific, CA, USA.
Cell proliferation evaluated by 3-[4,5-dimethylthiazol]-2,5-
diphenylterazolium bromide (MTT) assay
Cell proliferation was measured using MTT cell prolifera-
tion assay kit (Sigma Co., St. Louis, MO, USA) at 1, 3 and
7 days. Briefly, cells (3.0 × 105 per well) were seeded in a
96-well plate and incubated in DMEM (100 μl per well)
with 10% FBS overnight to allow cells to adhere to
the plate. The medium was changed with fresh medium
containing 17β-estradiol (10-7 < 10-10 M) and 2% FBS every
48 hours. At scheduled time points for MTT assay,
the culture medium was removed and the plate was
washed twice with PBS. After adding 100 μl of fresh
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solution, the plate was incubated at 37°C for 4 hours. The
enzyme activity in viable cells would convert MTT to dark
blue crystals of formazan. After discarding the medium
with MTT solution and adding 50 μl dimethylsulfoxide
(DMSO) to each well with thorough pipetting, the dark
blue crystals were dissolved and the colorless DMSO
turned purple. The plate was placed in the Infinite 200
PRO multimode microplate reader (Tecan Group Ltd.,
Switzerland) to read the absorbance at 570 nm.
Total collagen in medium measured by Sircol
collagen assay
Cells (3.0 × 105 per well) were seeded in a 6-well plate and
incubate in DMEM with 10% FBS. Cells were allowed to
adhere to the plate overnight, and then the medium was
changed to DMEM (2 ml per well) containing 17β-estradiol
(10-7 < 10-9 M) with 2% FBS. After 10 days, 200 μl sample
medium of each group was transfer to a 1.5 ml centrifuge
tube and mixed with 1.0 ml Sircol Dye Reagent (Biocolor,
Newtownabbey, Northern Ireland). The tubes were placed
in a gentle mechanical shaker for 30 minutes and then
centrifuged at 12,000 rpm for 10 minutes. The supernatant
was discarded. The unbound dye was removed from the
surface of the pellet and inner surface of the tube by rinsing
with Acid-Salt Wash Reagent. The remaining pellets were
mixed with 250 μl of alkali reagent and 200 μl of each
sample was transferred to each well of a 96-well plate to
measure the absorbance at 555 nm.
Total elastin in medium measured by FASTIN elastin
assay
Cells (3.0 × 105 per well) were seeded in a 6-well plate and
incubate in DMEM with 10% FBS. Cells were allowed to
adhere to the plate overnight, and then the medium
was changed to DMEM (2 ml per well) containing
17β-estradiol (10-7 < 10-9 M) with 2% FBS. After 10 days,
100 μl of sample medium in each group was transferred to
a 1.5 ml centrifuge tube and mixed well with equal volume
of Elastin Precipitating Reagent (Biocolor, Newtownabbey,
Northern Ireland) by vortexing. The tubes were centrifuged
at 10,000 g for 10 minutes. The supernatant was removed
and 1 ml of dye reagent was added into each tube. After
standing for 90 minutes, the tubes were centrifuged at
10,000 g for 10 minutes and unbound dye was drained off.
250 μl of Dye Dissociation Reagent was added to each tube
followed by vortexing to release the dye. The samples
were then transferred to a 96-well plate to measure the
absorbance at 513 nm.
RNA extraction
Cells (3.0 × 105 per well) were seeded in a 6-well plate
and incubate in DMEM with 10% FBS. After 24 hours,
17β-estradiol (10-7 < 10-9 M) with vehicle, ICI 182780(Fulvestrant; Sigma, USA), or LY-294002 (Sigma, USA)
were added to the cells and incubated for 24 hours.
After incubation, culture medium was discarded and
each well was washed with PBS twice. Cells were
lysed in a culture dish by adding 1 ml TRIZOL reagent
(Invitrogen Life Technologies, Carlsbad, CA, USA). The
homogenized samples were incubated for 5 minutes at
room temperature to permit complete dissociation of
the nucleoprotein complex. Samples were then shook
vigorously for 15 seconds after adding 0.2 ml chloroform
and centrifuged at 12,000 g for 10 minutes at 4°C. The
supernatant was removed. The RNA pellet was washed
once with 75% ethanol and centrifuged at 7500 g for
5 minutes at 4°C. RNA was air-dried for 5 minutes and
dissolved in DEPC-treated ddH2O.
Reverse transcription
1 μl oligo(dT), 1 μl 10 mM dNTP Mix, 500 ng total
RNA and distilled water with a total volume of 12 μl
were added to a nuclease-free microcentrifuge tube. The
tubes were heated to 65°C for 5 minutes and quickly
cooled on ice. After adding 4 μl 5X First-Strand Buffer,
2 μl 0.1 M DTT, 1 μl RNaseOUTTM and 1 μl (200 units) of
M-MLV RT (Invitrogen Life Technologies, Carlsbad, CA,
USA) to each tube, the tubes were incubated for 50 minutes.
The reaction was ended by heating at 70°C for 15 minutes.
Quantitative real-time Polymerase Chain Reaction (PCR)
Real-time PCR reaction was carried out using the Roche
Light Cycler and utilizing Roche SYBR Green reagents
(Roche, Basel, Switzerland) according to manufacturer’s
instruction. Each sample contained 2.5 mM MgCl2,
0.2 μM of each forward and backward primer, 1 μl DNA
master SYBR Green, and 1 μl cDNA. The reaction was
carried out with 1 cycle at 95°C for 10 minutes, followed by
40 cycles with a denaturing phase at 95°C for 15 seconds,
an annealing phase of 5 seconds at 60°C and an elongation
phase at 72°C for 15 seconds. Melting curve analysis was
done to verify the accuracy of the amplification before
reading the result. The sequences of specific primers used
in this study were summarized in Table 1. LY-294002
(Sigma-Aldrich Co.), a specific PI3K inhibitor, was used to
evaluate the role of PI3K pathway in downstream signaling
of estradiol.
Western blot
To evaluate the protein expression of p-JNK, p-ERK, p-p38,
and MMP-13 under the influence of estradiol, LF cells in
different experimental groups were incubated for 72 hours
before western blotting analysis. Antibodies specific to the
p-JNK, p-ERK, p-p38, and actin were purchased from Cell
Signaling Technology, Inc. Antibodies specific to MMP-13
was purchased from Abcam, plc. LF cells were then lysed
and centrifuged at 14,000 g for 10 min at 4°C. Equal
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gel and then transferred to nitrocellulose membrane,
followed by blocking with 5% bovine serum albumin (BSA)
for 1 h at room temperature. The membrane was
then incubated overnight at 4°C with rabbit monoclonal
antibody specific to the p-JNK, p-ERK, p-p38(1:1000), or
MMP-13(1:400). After three washes, the membrane
was incubated with anti-rabbit IgG conjugated with
horseradish peroxidase (HRP) for 1 h at room temperature.
Detection was performed with luminal chemiluminescent
systems. Quantitative data were obtained using a comput-
ing densitometer and Multi Gauge software version
3.0 (Fuji Photo Film Co., Ltd, Tokyo, Japan). ICI 182780
(Sigma-Aldrich Co.), an estrogen receptor antagonist, was
used for the blocking of estradiol effect in experimental
groups.
Statistical analysis
All data were expressed as mean ± standard error of the
mean (SEM). Comparison between the experimental
groups and the control group were measured using
Student’s t test. Non-parametric one sample Wilcoxon
test was used for the analysis of RT-PCR results. The
level of statistic significance was defined as p < 0.05.
Results
Estrogen receptors were found on both female and male
ligamentum flavum
Immunohistochemistry revealed estrogen receptor-β was
positively stained in both male and female LF cells with
similar density, while estrogen receptor-α was identified
on female LF cells with lower density and was barely
seen on cells from a male patient (Figure 1).Low dose estradiol increased proliferation at early culture
of LF cells
17β-estradiol at a concentration of 10-8 M, 10-9 M,
or 10-10 M significantly increased proliferation of ligamen-
tum flavum cells at 24 hours but not at Day 3 or Day 7 of
culture (Figure 2A, 2B, 2C). The influence of 17β-estradiol
on cell proliferation at 24 hours was inversely related to
the concentration (Figure 2A). 17β-estradiol of 10-7 M did
not influence cell proliferation at any experimental time
point (Figure 2A, 2B, 2C).
Estradiol decreased soluble collagen in the cultured
medium of LF cells but not at the transcription level
Measurement of soluble collagen and elastin in the
medium of cell culture ten days after the treatment of
17β-estradiol (10-7-10-9 M) using Sirocol collagen assay
and FASTIN elastin assay respectively revealed significant
decrease in collagen concentration (Figure 3 A). The
baseline amount of soluble elastin was low as compared
to collagen level in the culture medium. Estradiol did
not decrease the amount of elastin significantly at
Day 10 (Figure 3B). However, the results showed estradiol
treatment significantly lowered the collagen to elastin
ratio at day 10 (Figure 3C). We also examined the
influence of 17β-estradiol (10-7-10-9 M) on collagen and
elastin mRNA expression after 24 hours of treatment, but
mRNA expression of collagen did not yield significant
change (Figure 3D, 3E). Under high concentration of
17β-estradiol (10-7 M) treatment, the mRNA expression
of elastin increased.
Estradiol increased the expression of collagenase MMP-13
The matrix-degrading enzymes, matrix metalloprotienases
(MMPs), are a family of zinc-dependent endopeptidases
capable of degrading the components of the extracellular
matrix [21-23]. Specific MMPs had been noticed to be
overly expressed in human ligamentum flavum [24]. We
examined two collagenases (MMP-1 and MMP-13) and
two gelatinases (MMP-2 and MMP-9) in human LF cell
culture under the treatment of 17β-estradiol (10-7-10-9 M)
at 24 hours. Estradiol significantly up-regulated the
expression of MMP-13 mRNA. The expression of
MMP-13 mRNA increased 2.5 times especially with low
dose (10-9 M) 17β-estradiol (Figure 4A). However, estra-
diol did not significantly influence MMP-1, MMP-2, and
MMP-9 mRNA expression (data not shown).
Estrogen receptor antagonist could reverse the up-
regulation of MMP-13 expression level and protein level
caused by estradiol
We measured the expression of MMP-13 at mRNA and
protein levels (secreted in culture medium) under the
treatment of 10-9 M 17β-estradiol with or without an
estrogen receptor antagonist, ICI 182780 (10-7 M). We
Figure 1 Staining for estrogen receptors of LF cells. (A) and (C) showed ligamentum flavum cells taken from a female patient. (B) and (D)
showed ligamentum flavum cells taken from a male patient. In (A) and (B), cells were stained for estrogen receptor β. In (C) and (D), cells were
stained for estrogen receptor α. Positively stained cell are brown in color (arrow). Some cells in (C) and most of the cells in (D) were not stained
by antibodies showing blue in color (arrow heads).
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could be attenuated at both mRNA and protein levels
by blocking the estrogen receptors with ICI 182780
(Figure 4B and 4C).
Regulation of MMP-13 by estradiol might not be related
to mitogen-activated protein kinase (MAPK/ERK) pathway
Downstream signaling of estrogen receptors may involve
MAPK pathway or phosphoinositide 3-kinase (Pl3K/AKT)
pathway [25]. We analyzed downstream molecules of
MAPK pathway including p-ERK, p-JNK, and p-p38 by
Western blotting 6 hours and 24 hours after LF cells treated
with 10-9 M 17β-estradiol. No significant change was noted
while compared to the control group (Figure 5A and 5B).
Up-regulation of MMP-13 expression by estradiol could
be attenuated by blocking PI3K pathway
Another downstream signaling pathway of estrogen re-
ceptor, PI3K, was also investigated by quantitative real-
time PCR. MMP-13 mRNA expression stimulated by 10-
9 M 17β-estradiol at 24 hours could be attenuated by
adding LY-294002, an inhibitor of PI3K (Figure 5C).
Discussion
Hypertrophy of ligamentum flavum contributes to the
development of lumbar spinal stenosis, which is one of
the most common spinal disorders in the elderly patients
and frequently causes neurogenic claudication, functional
limitation and immobilization [1,26]. As menopause hasgreat influences on osteoporosis and other connective
tissue disorder, it will not be surprising if estradiol
plays a role in the regulation of collagen metabolism of
the ligamentum flavum and contributes to the patho-
physiological mechanisms of lumbar stenosis. Studying LF
cells can be difficult because the degenerative yellow
ligament in elderly has relatively low density of cells.
Therefore, we collected and grew cells from the ligamentum
flavum before immunohistochemical studies. We found
estrogen receptor-β presented on LF cells with similar
density in both male and female patients, while estrogen
receptor-α was barely seen in LF cells in male (Figure 1).
The gender difference in the distribution of estrogen
receptor-α in LF cells was similar to that in rat cardiomyo-
cytes in another study [27]. The estrogen-α and estrogen-β
receptors can form heterodimer to initiate transcription
[28] and demonstrate significant differences in their
response to anti-estradiols [29]. Those special regulatory
mechanisms explain the complex nature of estradiol’s
effects. Although we found the distribution of receptor-α
varied with different genders, we still had to pool the LF
cells from both genders to investigate estradiol’s
effects on LF cells due to limited sources of samples. We
evaluated the effects of estradiol of different concentrations
(10-7 M, 10-8 M, 10-9 M, and 10-10 M) on the proliferation
of cultured LF cells at 24 hours, day 3 and day 7. The
physiological range of serum estradiol in non-pregnant
women can be very wide. The highest concentration of
serum estradiol is about 10-9 M at preovulatory peak in
Figure 2 Effects of estradiol on proliferation of LF cells by MTT assay. Proliferation of ligamentum flavum cells was measured by MTT assay
at 24 hours (A), Day 3 (B) and Day 7 (C) treated with 17β-estradiol (10-7 >M, 10-8 M, 10-9 M, and 10-10 M). The level of proliferation was presented as
optical density (O.D.) of absorbance at 570 nm. (n = 6; * p <0.05).
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even lower in post-menopausal women. We found 10-7 M
17β-estradiol did not influence cell proliferation at
any time point during the experiments. However, in
the early stage (24 hours), 17β-estradiol with a concentra-
tion of 10-8 M, 10-9 M, or 10-10 M significantly increased
the proliferation of LF cells in an inversely dose-dependent
manner (Figure 2). Our results implied that a concentra-
tion of 17β-estradiol (10-7 M) above physiological rangemight prevent the proliferation of LF cells. While the
density of cultured cells increased (O.D. > 0.25 by
MTT assay) or the cells matured (cultured more than
3 days), proliferation of LF cells became more resistant to
the stimulation from 17β-estradiol of low concentration
(10-8 M, 10-9 M, or 10-10 M).
In addition to the proliferation of LF cells, metabolism
of extracellular matrix in ligamentum flavum may also
play an important role in lumbar spinal stenosis. Change
Figure 3 Effects of estradiol on the expressions of collagen and elastin. Total soluble collagen (A) and elastin (B) levels in cell culture media
were measured ten days after treatment of 17β-estradiol (10-7 M, 10-8 M, and 10-9 M). Collagen to elastin ratio (C) significantly decreased at day
10. The levels of type I collagen mRNA (D) and elastin mRNA (E) expression were compared to the internal control gene expression 24 hours after
treatment of 17β-estradiol (10-7 M, 10-8 M, and 10-9 M). (n = 6; * p <0.05).
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a sign of developing lumbar spinal stenosis in elder
patients [10]. We measured the soluble elastin and
collagen in the culture medium at Day 10 after the
treatment of 17β-estradiol (10-7 M, 10-8 M, 10-9 M) using
FASTIN and Sirocol assays respectively. We found soluble
collagen was reduced after administration of 17β-estradiol(Figure 3A). Interestingly, collagen to elastin ratio
decreased after LF cells were treated with 17β-estradiol
(Figure 3C). The results might indicate that the deficiency
of estradiol in elderly contributes to the aging processes
of the ligamentum flavum. In postmenopausal women,
hormone replacement therapy has benefit for skin because
estradiol may increase collagen and other extracellular
Figure 4 Estradiol regulated the expressions of matrix metalloproteinases. (A) Estradiol significantly increased the expression of MMP-13 at
24 hours (* p <0.05), but not those of MMP-1, MMP-2, and MMP-9 (not shown). (B) & (C) Up-regulation of expression of MMP-13 mRNA (B) and
protein (secreted in culture medium) (C) by 10-9 M 17β-estradiol could be attenuated by estrogen receptor antagonist (10-7 M ICI 182780). (n = 6;
* p <0.05) (E2: 17β-estradiol; ICI: ICI 182780).
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decreased soluble collagen in the culture medium of LF
cells. However, the yellow ligament is named for its
richness of elastin and the suppression of collagen in its
growing stage might have association with the high elastin
content in this special tissue. Since estradiol did not alter
mRNA expression of collagen (Figure 3D), the reductionFigure 5 PI3K pathway was involved in the regulation of MMP-13 exp
p-JNK and p-38 was analyzed by Western blotting at 6 hours (A) and 24 hours
noted in comparison with control group. Up-regulation of expression of MMP-
adding LY-294002, an inhibitor of PI3K (C). (E2: 17β-estradiol; LY: LY-294002).of collagen might be due to its degradation. The matrix-
degrading enzymes, matrix metalloprotienases (MMPs),
are a family of zinc-dependent endopeptidases capable
of degrading the components of the extracellular
matrix [21-23]. Specific MMPs had been noticed to be
overly expressed in human ligamentum flavum [24].
In this study, we examined the expression of MMP-1,ression. Downstream signaling of MAPK pathway including p-ERK,
(B) after the treatment of 10-9 M 17β-estradiol. No significant change was
13 mRNA after the treatment of 10-9 M 17β-estradiol was attenuated by
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17β-estradiol (10-7-10-9 M) at 24 hours. 17β-estradiol
significantly up-regulated the expression of MMP-13
mRNA to 2.5 times at the concentration of 10-9 M.
Nonetheless, the expression of MMP-13 caused by
17β-estradiol could be suppressed with an estrogen
receptor antagonist (ICI 182780) (Figure 4B and 4C).
This confirmed the expression of MMP-13 could be
resulted from the activation of estrogen receptors.
Activation of estrogen receptors will send signals to the
nucleus through the mitogen-activated protein kinase
(MAPK/ERK) pathway or phosphoinositide 3-kinase
(Pl3K/AKT) pathway [25]. Yet, the downstream proteins
of MAPK pathway evaluated by western blot did not show
significant change 6 and 24 hours after the treatment of
17β-estradiol (10-9 M) with and without estrogen receptor
antagonist (ICI 182780) (Figure 5A and 5B). On the
other hand, adding an inhibitor of PI3K pathway
could suppress the expression of MMP-13 stimulated
by 17β-estradiol (Figure 5C). As a result, we believed
that 10-9 M 17β-estradiol regulated the expression of
MMP-13 via the PI3K downstream signaling and, in
turn, played a role in the collagen metabolism. Park et al
also reported the increased expression of MMP-13 by the
ligamentum flavum fibroblasts in patients with lumbar
stenosis [24]. However, other studies suggested the
expression of tissue inhibitors of metalloproteinases
(TIMPs) increased in the hypertrophic ligamentum
flavum [30]. On the basis of our study and those previous
findings, it is difficult to simply conclude a specific
role of estradiol at low concentration (10-9 M) in the
pathophysiological mechanism of ligamentum flavum
hypertrophy. However, a possible explanation is that
17β-estradiol at a concentration of 10-9 M may contribute
to the degradation of extracellular matrix components via
the PI3K pathway. The catabolic extracellular matrix
products may consequently stimulate the expression of
TIMPs in vivo. Furthermore, change in the ratio of
elastin to collagen then contributes to the development of
degenerative hypertrophic change of the ligamentum
flavum. Thus, deficiency of estradiol in menopausal female
might alter the homeostasis of extracellular matrix and
play a role in the development of lumbar stenosis.
Nonetheless, further understanding and studies on the
physiological changes of estradiol concentration during
different stages of aging, expression levels of MMPs and
TIMPs for the various degrees of elastin degradation,
fibrosis, and hypertrophy of the ligamentum flavum
are necessary to define the exact relationship between
estradiol and hypertrophy of ligamentum flavum.
Conclusion
The association between estradiol and the ligamentum
hypertrophy was seldom explored before. In this study,we revealed that estradiol increased early proliferation of
LF cells in a dose dependent manner. Estradiol could
decrease collagen levels, lower collagen to elastin ratio,
and increase MMP-13 through PI3K pathway. From
these findings, we suggested that estradiol could play a
role in regulating the development of lumbar spinal
stenosis through the alterations of both cell viability and
matrix metabolism of the ligamentum flavum.
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